Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A comprehensive 2024 review of 36 studies (1993-2024) confirms BPC-157 promotes healing through growth factor upregulation, VEGF/VEGFR2 expression modulation, and NO system regulation
The FDA has restricted compounding pharmacies from producing BPC-157 due to safety concerns, and the World Anti-Doping Agency classifies it as an S0 Unapproved Substance. Manufacturing and distribution are largely underground, raising quality control concerns for black-market products
Retinol or chemical peels (with physician supervision and Rx strength) can be used to tighten and thicken skin in the under eye - and these strong resurfacing chemicals are really the only skincare products that can reverse damage in this area
The degenerative environment of chronic tendinopathy lacks the active cellular repair response present in acute injuries, and BPC-157's ability to initiate fibroblast migration and growth factor receptor upregulation addresses the biological deficit underlying the chronic state
Chen 2020)
US$ 27.53
US$ 21.03
US$ 27.81
US$ 25.86
US$ 21.18
US$ 22.24
US$ 21.21
US$ 26.73
